BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24931255)

  • 1. Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virus.
    Weng M; Zhang M; Qin Y; Gong W; Tang Z; Quan Z; Wu K
    Chin Med J (Engl); 2014; 127(12):2350-6. PubMed ID: 24931255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.
    Weng M; Gong W; Ma M; Chu B; Qin Y; Zhang M; Lun X; McFadden G; Forsyth P; Yang Y; Quan Z
    Mol Cancer; 2014 Apr; 13():82. PubMed ID: 24725816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
    Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
    Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Seo E; Wakayama M; Murata T; Todoroki T; Tanaka N; Hamada H; Yokoyama KK
    Cancer Res; 2003 Aug; 63(15):4434-40. PubMed ID: 12907616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.
    Kellish P; Shabashvili D; Rahman MM; Nawab A; Guijarro MV; Zhang M; Cao C; Moussatche N; Boyle T; Antonia S; Reinhard M; Hartzell C; Jantz M; Mehta HJ; McFadden G; Kaye FJ; Zajac-Kaye M
    J Clin Invest; 2019 Apr; 129(6):2279-2292. PubMed ID: 31033480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.
    Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY
    Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.
    Lun X; Alain T; Zemp FJ; Zhou H; Rahman MM; Hamilton MG; McFadden G; Bell J; Senger DL; Forsyth PA
    Cancer Res; 2010 Jan; 70(2):598-608. PubMed ID: 20068158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells.
    Rahman MM; Gutierrez-Jensen AD; Glenn HL; Abrantes M; Moussatche N; McFadden G
    J Virol; 2021 Jun; 95(14):e0015121. PubMed ID: 33952639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.
    Madlambayan GJ; Bartee E; Kim M; Rahman MM; Meacham A; Scott EW; McFadden G; Cogle CR
    Leuk Res; 2012 May; 36(5):619-24. PubMed ID: 22341701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.
    Zemp FJ; McKenzie BA; Lun X; Maxwell L; Reilly KM; McFadden G; Yong VW; Forsyth PA
    PLoS One; 2013; 8(6):e65801. PubMed ID: 23762429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells.
    Rahman MM; Bagdassarian E; Ali MAM; McFadden G
    Sci Rep; 2017 Nov; 7(1):15710. PubMed ID: 29146961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer.
    Villa NY; Franco LS; McFadden G
    Methods Mol Biol; 2020; 2058():95-110. PubMed ID: 31486033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.
    Wennier ST; Liu J; Li S; Rahman MM; Mona M; McFadden G
    Mol Ther; 2012 Apr; 20(4):759-68. PubMed ID: 22233582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer.
    Rahman MM; van Oosterom F; Enow JA; Hossain M; Gutierrez-Jensen AD; Cashen M; Everts A; Lowe K; Kilbourne J; Daggett-Vondras J; Karr TL; McFadden G
    Cancer Res Commun; 2023 Jun; 3(6):952-968. PubMed ID: 37377603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of autologous bone marrow pre-loaded
    Villa NY; Rahman MM; Mamola J; Sharik ME; de Matos AL; Kilbourne J; Lowe K; Daggett-Vondras J; D'Isabella J; Goras E; Chesi M; Bergsagel PL; McFadden G
    Oncotarget; 2022; 13():490-504. PubMed ID: 35251496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
    Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL
    Viruses; 2020 May; 12(5):. PubMed ID: 32397134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo.
    Wang J; Yu Y; Yan Z; Hu Z; Li L; Li J; Jiang X; Qian Q
    Oncol Rep; 2013 Aug; 30(2):833-41. PubMed ID: 23727990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development.
    Matsuda R; Yoshikawa M; Kimura H; Ouji Y; Nakase H; Nishimura F; Nonaka J; Toriumi H; Yamada S; Nishiofuku M; Moriya K; Ishizaka S; Nakamura M; Sakaki T
    Cell Transplant; 2009; 18(1):39-54. PubMed ID: 19476208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells.
    Liu J; Wennier S; Zhang L; McFadden G
    J Virol; 2011 Apr; 85(7):3270-82. PubMed ID: 21248034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.